That this House welcomes the £260,000 grant for research into diabetes at Queens University Belfast from the British Heart Foundation as a major help to combating the link between diabetes and cardiovascular disease; and wishes Dr Andrians Margariti every success for her and team doing the research.

That this House welcomes the £260,000 grant for research into diabetes at Queens University Belfast from the British Heart Foundation as a major help to combating the link between diabetes and cardiovascular disease; and wishes Dr Andrians Margariti every success for her and team doing the research.

That this House notes the decision by NICE to stop the availability of the drug anakinra for patients who have been diagnosed with the rare condition Tumour Necrosis Factor Receptor Periodic Syndrome after March 2016; further notes that the decision was to allow the use of anakinra in exceptional circumstances; believes that the case of Harriet North from Morecambe and Lunesdale is an exceptional circumstance as it is one of the worst cases of the illness in the 70 cases in the county; and urges NHS England to reconsider their decision and to allow Harriet to be prescribed anakinra to not only improve her quality of life but extend her life.

That this House notes the decision by NICE to stop the availability of the drug anakinra for patients who have been diagnosed with the rare condition Tumour Necrosis Factor Receptor Periodic Syndrome after March 2016; further notes that the decision was to allow the use of anakinra in exceptional circumstances;...

That this House recognises the impact of living with a terminal illness and highlights the need for care and support for all those affected; is deeply concerned that as many as 110,000 people across the UK who should have access to this high quality care and support are currently missing out, often those over the age of 85 or with conditions other than cancer; and supports the work of Marie Curie services across the UK to help meet this demand in their Great Daffodil Appeal launch and throughout 2017.

That this House recognises the impact of living with a terminal illness and highlights the need for care and support for all those affected; is deeply concerned that as many as 110,000 people across the UK who should have access to this high quality care and support are currently missing...

That this notes that 3 March 2017 is Big Yellow Friday, and congratulates the Children's Liver Disease Foundation on its work in raising awareness, promoting research and providing information and support for those affected by a life-threatening liver disease; further notes with concern there are over 100 different liver diseases that can affect babies, children or young people, most of which are life-threatening and all of which have no cure, meaning a lifetime of care; commends the work of the Children's Liver Disease Foundation in providing literature and educational tools, personal family support and over £8million for research projects, including the development of ground-breaking liver cell transplantation therapies and funding projects to improve understanding of auto-immune liver diseases, since its formation in 1980; further congratulates the Children's Liver Disease Foundation and the Big Yellow Friday supporters for raising £661,484 since 2008; recognises that every penny raised has been used to fund vital services and life-changing projects for children and families affected by childhood liver disease across the UK; commends all those taking part in Big Yellow Friday 2017 and showing support for children affected by childhood liver disease and their families; and calls on the Government to work closely with all national liver-disease charities to help ensure childhood liver diseases are understood, prevented and treated effectively, ensuring that babies, children, young people, their families and adults diagnosed in childhood achieve their full potential.

That this notes that 3 March 2017 is Big Yellow Friday, and congratulates the Children's Liver Disease Foundation on its work in raising awareness, promoting research and providing information and support for those affected by a life-threatening liver disease; further notes with concern there are over 100 different liver diseases...

That this House supports Ovarian Cancer Awareness Month which takes place in March 2017; notes that over 7,000 women are diagnosed with ovarian cancer across the UK each year; is concerned that just one in five women are able to name the lead symptom of bloating; recognises that early diagnosis saves lives and that awareness of the symptoms of ovarian cancer is key if more women are to be diagnosed sooner; further recognises that the four key symptoms of ovarian cancer are persistent bloating, pelvic or abdominal pain, feeling full and a loss of appetite and increased urinary urgency or frequency; further supports the work of charities Target Ovarian Cancer, Ovarian Cancer Action, Ovacome, The Eve Appeal and others to raise awareness of the symptoms of this deadly disease; welcomes the Be Clear on Cancer pilot currently running in the East and West Midlands which aims to raise awareness of all abdominal symptoms that could be cancer; and calls on the Government and devolved administrations to act to ensure that all women know the symptoms of ovarian cancer and that more women are diagnosed early.

That this House supports Ovarian Cancer Awareness Month which takes place in March 2017; notes that over 7,000 women are diagnosed with ovarian cancer across the UK each year; is concerned that just one in five women are able to name the lead symptom of bloating; recognises that early diagnosis...

That this House welcomes Stand Up To Cancer 2016 fundraising partnership between Cancer Research UK and public service broadcaster Channel 4; recognises that one in two people in the UK will be affected by cancer in their lifetime; notes the importance of Cancer Research UK's translational research, with clinical trials which turn scientific breakthroughs into practical new cancer treatments and tests; further notes that £16 million has been raised so far by the campaign this year and that more than £40 million has been raised through the Stand Up To Cancer and Channel 4 partnership in the UK to date, resulting in 30 funded trials and projects, involving more than 9,000 cancer patients; and pledges its support for Stand Up To Cancer 2016.

That this House welcomes Stand Up To Cancer 2016 fundraising partnership between Cancer Research UK and public service broadcaster Channel 4; recognises that one in two people in the UK will be affected by cancer in their lifetime; notes the importance of Cancer Research UK's translational research, with clinical trials...

That this House recognises that 10 million people in the UK are living and working with arthritis and musculoskeletal conditions; further recognises that the pain, isolation and fatigue of arthritis and musculoskeletal conditions can affect every aspect of the daily lives of the people living with these conditions, interfering with everyday activities, whether that be at work, travelling or enjoying leisure time; recognises that the prevalence of arthritis and musculoskeletal conditions is set to increase due to rising obesity and the ageing population and that this increased prevalence will have a knock-on impact on health and care services unless action is taken; and recognises the need to raise awareness of the condition in the run-up to World Arthritis Day and supports Arthritis Research UK's Share Your Everyday campaign so that hon. Members can share their experiences of arthritis and encourage others across the country to do the same, helping millions to push back the limits of their condition.

That this House recognises that 10 million people in the UK are living and working with arthritis and musculoskeletal conditions; further recognises that the pain, isolation and fatigue of arthritis and musculoskeletal conditions can affect every aspect of the daily lives of the people living with these conditions, interfering with...

That this House joins people with Down’s syndrome, their families and advocacy groups supporting the Don’t Screen Us Out campaign in being deeply concerned that the UK National Screening Committee has proposed that cell-free DNA (cfDNA) testing be introduced into the UK’s Fetal Anomaly Screening Programme (FASP); acknowledges that these proposals are projected to lead to 25 fewer miscarriages, but are also projected to result in 92 more children with Down’s syndrome being terminated each year, given that 90 per cent of babies identified with Down’s syndrome are terminated annually, having a profound and discriminatory effect on the community of people with Down’s syndrome; notes that this violates the UK’s treaty obligations to the UN Convention of the Rights of Persons with Disabilities (CRPD); considers that the current lack of non-directional medial support and balanced information for parents whose child is diagnosed with foetal disability constitutes a failure to implement article 23, section 3 of the CRPD which calls for early and comprehensive support for children with Down’s and their families; calls on the Government to delay implementation of cfDNA screening until reforms are introduced that adequately deliver this support; and urges that a formal inquiry be undertaken to ensure the FASP is fully compliant with the CRPD and other relevant disability rights standards.

That this House joins people with Down’s syndrome, their families and advocacy groups supporting the Don’t Screen Us Out campaign in being deeply concerned that the UK National Screening Committee has proposed that cell-free DNA (cfDNA) testing be introduced into the UK’s Fetal Anomaly Screening Programme (FASP); acknowledges that these...

That this House notes that the National Institute for Health and Care Excellence (NICE) has found Orkambi to be effective and important for managing cystic fibrosis; regrets that uncertainty around its long-term effect and its high cost means NICE cannot yet recommend the drug to the NHS; commends the initiative of the Cystic Fibrosis Trust, consistent with the Government's own Accelerated Access Review, to accelerate access to the drug while informing assessment of longer-term effects through use of its UK Cystic Fibrosis Data Registry; and urges cooperation between the NHS and drug manufacturer Vertex to ensure that the 3,000 patients who could see huge health benefits from Orkambi are able to do so.

That this House notes that the National Institute for Health and Care Excellence (NICE) has found Orkambi to be effective and important for managing cystic fibrosis; regrets that uncertainty around its long-term effect and its high cost means NICE cannot yet recommend the drug to the NHS; commends the initiative...

That this House recognises World AIDS Day 2015 which takes place on 1 December 2015; further recognises that the day allows for people throughout the world to unite in support of the fight against HIV; notes that many parliamentarians, as well as the wider public, have shown their support for the initiative by wearing a red ribbon; further notes that approximately 100,000 people are currently living with HIV in the UK, whilst an estimated 34 million people have HIV worldwide; commends the Scottish Government for spending £28 million this year to deliver its revised framework on this issue and to tackle the stigma around HIV infection; and calls on the Government to show its support for World AIDS Day by committing to fight prejudice and improve education concerning HIV.

That this House recognises World AIDS Day 2015 which takes place on 1 December 2015; further recognises that the day allows for people throughout the world to unite in support of the fight against HIV; notes that many parliamentarians, as well as the wider public, have shown their support for...

That this House is concerned that, of the estimated 11,300 blood cancer patients in the UK who will need a stem cell transplant in the next five years, one in eight will fail to find the matching donor they need; is further concerned that the odds of finding a donor drop significantly for patients from black, Asian and minority ethnic backgrounds; is concerned that, of those who do receive a stem cell transplant, over a third of adults and almost a fifth of children will not survive the first year; notes that, by 2020, over 16,000 post-transplant patients will be living with the long-term side-effects and complications of their treatment and are currently not guaranteed access to adequate care and support; therefore supports the publication of Anthony Nolan's Destination: Cure report which makes the case for action to be taken in response to these challenges, including ongoing investment to ensure continued growth of the UK's adult donor and donated cord blood stem cell supply, robust support for research infrastructure that drives improvement of outcomes for all patients, including a national stem cell transplantation trials network and resource for data collection, and a national care pathway for at least five years after transplant to ensure that patients are guaranteed access to high quality care which meets their long-term needs; and calls on the Government to do all it can to support the recruitment of donors, boost scientific research and provide long-term care for patients in need.

That this House is concerned that, of the estimated 11,300 blood cancer patients in the UK who will need a stem cell transplant in the next five years, one in eight will fail to find the matching donor they need; is further concerned that the odds of finding a donor...

That this House commends the organisers, speakers and attendees at the seventh International Symposium of the Diabetic Foot; notes that the symposium is a large and influential health conference held in The Hague, to share best practice on treating and preventing the complications of diabetes; is deeply concerned that there are over 70 lower limb amputations every week as a direct result of diabetes; further notes that effective management of diabetes is vital in preventing these serious operations; and urges the Government to provide the resources, specialist diabetes teams and educational materials necessary for preventing complications arising from serious diabetes.

That this House commends the organisers, speakers and attendees at the seventh International Symposium of the Diabetic Foot; notes that the symposium is a large and influential health conference held in The Hague, to share best practice on treating and preventing the complications of diabetes; is deeply concerned that there...

That this House notes that 25 to 31 January 2015 is Cervical Cancer Prevention Week, which is aimed at raising awareness of the causes and symptoms of cervical cancer and improving prevention efforts; further notes that eight women are diagnosed with, and three women die from, cervical cancer every day, despite the fact that it is largely preventable through HPV vaccination and cervical screening; further notes that, although all women aged 25 to 64 are invited to a free cervical screening test every three to five years, over 20 per cent, particularly those from disadvantaged areas, do not attend for screening; asks that relevant community and age-specific information is made available to women about cervical cancer symptoms, prevention and related issues; recognises what it considers to be the excellent work of Jo's Cervical Cancer Trust in supporting women and their families; and asks hon. Members, clinicians and policymakers to join the fight to eradicate cervical cancer.

That this House notes that 25 to 31 January 2015 is Cervical Cancer Prevention Week, which is aimed at raising awareness of the causes and symptoms of cervical cancer and improving prevention efforts; further notes that eight women are diagnosed with, and three women die from, cervical cancer every day,...

That this House notes that the UK has the highest incidence of oesophageal adenocarcinoma in the world and that incidence is rising; further notes that there are over 8,000 people diagnosed with oesophageal cancer every year in the UK; acknowledges that the survival rate for oesophageal cancer is one of the worst of any cancer, with only 15 per cent survival after five years; further notes that diagnosis for the condition Barrett's oesophagus which can lead to oesophageal cancer is low and that public awareness of the significance of persistent heartburn as a risk factor is very low; welcomes the work of the Oesophageal Cancer Westminster Campaign, a campaign group of patient groups, clinical experts, industry and bereaved families; further welcomes the national Be Clear on Cancer campaign on oesophageal cancer; and calls for the Government and the Department of Health to regard the diagnosis and treatment of Barrett's oesophagus and oesophageal cancer as a national priority to save lives.

That this House notes that the UK has the highest incidence of oesophageal adenocarcinoma in the world and that incidence is rising; further notes that there are over 8,000 people diagnosed with oesophageal cancer every year in the UK; acknowledges that the survival rate for oesophageal cancer is one of...

That this House welcomes the announcement that Breakthrough Breast Cancer and Breast Cancer Campaign will merge in Spring 2015; recognises that united, they will become the single largest breast cancer research community in the UK, responsible for addressing the critical gaps in breast cancer knowledge and research; supports their shared ambition that by 2050 no one will die from breast cancer; congratulates both charities and all their supporters on their efforts to beat breast cancer thus far; and wishes them every success for the future.

That this House welcomes the announcement that Breakthrough Breast Cancer and Breast Cancer Campaign will merge in Spring 2015; recognises that united, they will become the single largest breast cancer research community in the UK, responsible for addressing the critical gaps in breast cancer knowledge and research; supports their shared...

That this House is alarmed by Action on Sugar's report that a quarter of supermarket fruit drinks contain more sugar than the equivalent volume of Coca-Cola; notes that these drinks are commonly advertised as healthy and targeted at children; further notes a quarter of the products tested met or exceeded the maximum daily adult intake recommended by the World Health Organisation; is concerned such products are contributing to record levels of tooth decay, obesity and type 2 diabetes among children; and calls on the Government to implement legislation to reduce levels of sugar content in food and drink products.

That this House is alarmed by Action on Sugar's report that a quarter of supermarket fruit drinks contain more sugar than the equivalent volume of Coca-Cola; notes that these drinks are commonly advertised as healthy and targeted at children; further notes a quarter of the products tested met or exceeded...

That this House notes that, whilst the introduction of vaccinations has been effective in reducing levels of pneumococcal infection in children, pneumococcal infection remains a significant public health risk, particularly among other vulnerable groups, including those aged 65 and over; expresses concern that around 84,000 people are hospitalised due to pneumococcal community-acquired pneumonia in the UK every year, with around half of these cases amongst those aged 65 and over; further notes that an estimated £269 million is spent on hospitalising adults with pneumococcal community-acquired pneumonia each year, of which around £135 million relates to those aged 65 and over; welcomes the Joint Committee on Vaccination and Immunisation's intention to conduct a review of the adult vaccination programme, considering the latest evidence on the epidemiology and cost effectiveness of adult pneumococcal disease vaccination; and expresses concern that this review is intended to take six months, potentially placing more vulnerable adults at risk.

That this House notes that, whilst the introduction of vaccinations has been effective in reducing levels of pneumococcal infection in children, pneumococcal infection remains a significant public health risk, particularly among other vulnerable groups, including those aged 65 and over; expresses concern that around 84,000 people are hospitalised due to...

That this House notes that there are more than 1.2 million people in the UK on long-term warfarin treatment, many of whom are receiving excellent care and support in managing their condition; welcomes the first Patient Choice Awards event held in Parliament by the Anticoagulation Self-Monitoring Alliance to celebrate the excellent work that healthcare professionals are doing across the UK to support people on long-term warfarin wishing to self-monitor their blood clotting levels; congratulates the award winners for delivering the highest quality of care and professionalism for their patients; and calls on the Government to work closely with NHS England and clinical commissioning groups to ensure that the option of self-monitoring is made available to as many people on long-term warfarin as possible.

That this House notes that there are more than 1.2 million people in the UK on long-term warfarin treatment, many of whom are receiving excellent care and support in managing their condition; welcomes the first Patient Choice Awards event held in Parliament by the Anticoagulation Self-Monitoring Alliance to celebrate the...

That this House notes that 21 June 2014 marks International Motor Neurone Disease (MND) Awareness Day which seeks to improve public understanding of MND, a progressive and terminal disease that attacks motor neurones in the brain and spinal cord; recognises the important work that MND Scotland and the MND Association do to raise awareness and to assist those affected by the disease, including those who care for people with MND; further notes that MND has no cure or known cause, with half of those diagnosed dying within 14 months; and calls on the Government to invest in research into MND and to improve support for those affected.

That this House notes that 21 June 2014 marks International Motor Neurone Disease (MND) Awareness Day which seeks to improve public understanding of MND, a progressive and terminal disease that attacks motor neurones in the brain and spinal cord; recognises the important work that MND Scotland and the MND Association...

That this House is delighted that Stephen Sutton has been posthumously recognised with an MBE in this year's Queen's Birthday Honours for his tireless fundraising for the Teenage Cancer Trust; notes that this honour recognises Stephen's continued fearlessness right up until his death at the age of 19 years in May 2014; and further notes that Stephen was awarded the Kids Count Most Inspirational Young Person 2013 Award; and further notes that his work has now raised over four million pounds and elevated the awareness of young people living with cancer across the UK and that commitment continues to act as an inspiration for millions of people throughout the world.

That this House is delighted that Stephen Sutton has been posthumously recognised with an MBE in this year's Queen's Birthday Honours for his tireless fundraising for the Teenage Cancer Trust; notes that this honour recognises Stephen's continued fearlessness right up until his death at the age of 19 years in...